Vanda Pharmaceuticals (VNDA) Amortizatization of Intangibles (2010 - 2026)

Vanda Pharmaceuticals has disclosed Amortizatization of Intangibles across 17 years of filings, most recently posting $136000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $136000.0, down 81.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (down 7.74% YoY), and the FY2025 annual result was $7.0 million, changed 0.19% from the prior year.
• Amortizatization of Intangibles came in at $136000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $1.8 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $2.3 million in Q1 2023 to a low of $136000.0 in Q1 2026.
• The 5-year median for Amortizatization of Intangibles is $1.5 million (2024), against an average of $1.2 million.
• Across the five-year window, Amortizatization of Intangibles surged 472.0% in 2023 and slumped 81.84% in 2026, its largest moves.
• Vanda Pharmaceuticals' Amortizatization of Intangibles stood at $1.8 million in 2022, then plunged by 45.78% to $990000.0 in 2023, then jumped by 50.91% to $1.5 million in 2024, then gained by 17.27% to $1.8 million in 2025, then tumbled by 92.24% to $136000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $136000.0 (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.